Remote Jobs at SystImmune

SystImmune

51 - 200 employees

Founded 2014

🧬 Biotechnology

💊 Pharmaceuticals

🏥 Healthcare

💰 $50M Series B - Syntimmune on 2017-06

Biotechnology • Pharmaceuticals • Healthcare

SystImmune is a clinical-stage biotechnology company focused on discovering and developing antibody-based cancer therapies. It uses proprietary technology platforms (AIDP — AI-powered drug discovery, HIRE ADC — an ADC platform, GNC — multi-specific antibody discovery/engineering, and SEBA — bispecific antibody platform) to design ADCs, bispecific antibodies, peptides and protein therapeutics and to advance candidates from discovery through preclinical and clinical development to commercialization. Public information highlights a robust oncology pipeline (including izalontamab brengitecan / Iza‑bren with regulatory approvals in China and breakthrough therapy designation from the U. S. FDA), multiple clinical data presentations, and a collaboration with Bristol Myers Squibb.